The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?

Publisher： Jaypee Infomedia

E-ISSN： 0975-1947|6|2|55-57

ISSN： 0974-0333

Source： Journal of Current Glaucoma Practice, Vol.6, Iss.2, 2012-05, pp. : 55-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-VEGF Treatment of Glaucoma

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 126-130

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab

By Park Sung Chul   Su Daniel   Tello Celso  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1641-1647

Informa Healthcare

Access to resources Recommend Favorite

5.1.2. Anti-VEGF

By  

International Journal of Medical and Biological Frontiers, Vol. , Iss. , 2016-04 ,pp. : 88-88

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Resistance to Anti-VEGF Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 1, 2004-01 ,pp. : 51-64

Bentham Science Publishers

Access to resources Recommend Favorite

Are Intravitreal Anti-VEGF Antibodies Safe?

By Tezel Tongalp   Kaplan Henry  

Ocular Immunology and Inflammation, Vol. 15, Iss. 1, 2007-01 ,pp. : 1-2

Informa Healthcare

Access to resources Recommend Favorite